Patients with solid tumor malignancies had better survival after ICI therapy if they were obese than if they had a normal BMI.

GLP-1 receptor agonist prescriptions increased significantly during study period across all categories of BMI, in dose-response manner.

Physicians should counsel patients considering whether to start treatment for chronic noncancer pain about benefits and harms of cannabis or cannabinoids.

Reducing the infusion time for nivolumab and pembrolizumab to 10 minutes is feasible and safe, according to researchers.

“AI can enhance clinical decision-making for common acute symptoms in a virtual urgent care setting,” the authors write. “Thoughtful integration of AI into clinical practice, combining its strengths ...

(HealthDay News) — The Geriatric Nutritional Risk Index (GNRI) is a reliable predictive marker for overactive bladder (OAB) in the elderly, according to a study published online Feb. 10 in Frontiers ...

The FDA has granted Priority Review to pegcetacoplan for the treatment of C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis.

The choice of iron preparation in children with iron-deficiency anemia related to chronic kidney disease (CKD) includes tolerance and response.

Enfortumab vedotin plus pembrolizumab is more effective than chemotherapy as first-line treatment for metastatic urothelial cancer, data suggest.

Virtual reality relaxation program can reduce pain intensity, with significant changes in brain functional connectivity patterns.

SGLT2 inhibitor use was not associated with an increased risk for postoperative diabetic ketoacidosis among patients with type 2 diabetes.

Semaglutide associated with increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes.